EUVIMEDScopri EUVIMED
Fallbericht

Pulmonary Artery Denervation for Refractory Sjögren's Syndrome‐Associated Pulmonary Arterial Hypertension: A Case Report of Combined Hemodynamic and Renal Recovery

Jingjing Hu, Fengyou Yao iD

Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 1847-1850

DOI: 10.1002/ccd.70546 ↗

At a glance

Fallbericht in Catheterization and Cardiovascular Interventions, published online on 2026-03-09. Written by Jingjing Hu and 1 co-authors. Institution: Fifth People's Hospital of Chengdu, Chengdu, China. Major MEDLINE topics: Sjogren's Syndrome, Pulmonary Artery, Arterial Pressure, Pulmonary Arterial Hypertension. 5 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

A 31‐year‐old woman with primary Sjögren's syndrome presented with severe pre‐capillary pulmonary arterial hypertension (mean pulmonary arterial pressure 51 mmHg, pulmonary vascular resistance 14.7 Wood units) and active renal impairment (24‐hour urinary protein 1290 mg). Despite initial immunosuppressive therapy and dual oral PAH‐targeted treatment with ambrisentan and tadalafil, she remained at high risk. She subsequently underwent pulmonary artery denervation (PADN) using a 45‐mm ablation catheter with 120‐second radiofrequency applications at three sites on the main pulmonary artery. At 2‐month follow‐up, she demonstrated significant symptomatic improvement to WHO functional class I, with a 6‐minute walk distance of 320 meters, improved hemodynamics (mean pulmonary arterial pressure 35 mmHg, pulmonary vascular resistance 5.63 Wood units), and a reduced NT‐proBNP level of 320 pg/mL, achieving an intermediate‐low risk status according to the 2022 ESC/ERS guidelines. Renal function also improved (24‐hour urinary protein 158 mg). This case suggests that PADN may be an effective adjunctive interventional strategy for refractory autoimmune PAH, even with concurrent renal involvement, facilitating simultaneous cardiopulmonary and renal recovery.

Subjects

MeSH terms (MEDLINE)

Sjogren's SyndromePulmonary ArteryArterial PressurePulmonary Arterial HypertensionKidneyCatheter AblationHumansFemaleTreatment OutcomeAdultRecovery of FunctionAntihypertensive AgentsImmunosuppressive Agents

Author keywords

Sjögren's syndromecase reportpulmonary arterial hypertensionpulmonary artery denervationrenal impairment

Substances

Antihypertensive AgentsImmunosuppressive Agents

Authors and institutions

  • Fifth People's Hospital of Chengdu, Chengdu, China.

ORCID profiles: Fengyou Yao

Cite

APA

Hu, J., & Yao, F. (2026). Pulmonary Artery Denervation for Refractory Sjögren's Syndrome‐Associated Pulmonary Arterial Hypertension: A Case Report of Combined Hemodynamic and Renal Recovery. Catheterization and Cardiovascular Interventions, 107(6), 1847-1850. https://doi.org/10.1002/ccd.70546

Vancouver

Hu J, Yao F. Pulmonary Artery Denervation for Refractory Sjögren's Syndrome‐Associated Pulmonary Arterial Hypertension: A Case Report of Combined Hemodynamic and Renal Recovery. Catheterization and Cardiovascular Interventions. 2026;107(6):1847-1850. doi:10.1002/ccd.70546

BibTeX
@article{Hu2026,
  author = {Hu, Jingjing and Yao, Fengyou},
  title = {Pulmonary Artery Denervation for Refractory Sjögren's Syndrome‐Associated Pulmonary Arterial Hypertension: A Case Report of Combined Hemodynamic and Renal Recovery},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {6},
  pages = {1847--1850},
  doi = {10.1002/ccd.70546}
}
Start for free →